000 01559 a2200433 4500
005 20250518020252.0
264 0 _c20191118
008 201911s 0 0 eng d
022 _a1558-3597
024 7 _a10.1016/j.jacc.2018.10.057
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDemissei, Biniyam G
245 0 0 _aCardiovascular Function Phenotypes in Response to Cardiotoxic Breast Cancer Therapy.
_h[electronic resource]
260 _bJournal of the American College of Cardiology
_c01 2019
300 _a248-249 p.
_bdigital
500 _aPublication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnthracyclines
_xadverse effects
650 0 4 _aAntineoplastic Agents, Immunological
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCardiotoxins
650 0 4 _aElectrocardiography
650 0 4 _aFemale
650 0 4 _aHeart Diseases
_xchemically induced
650 0 4 _aHumans
650 0 4 _aProspective Studies
650 0 4 _aStroke Volume
650 0 4 _aTrastuzumab
_xadverse effects
700 1 _aFinkelman, Brian S
700 1 _aHubbard, Rebecca A
700 1 _aSmith, Amanda M
700 1 _aNarayan, Hari K
700 1 _aNarayan, Vivek
700 1 _aShah, Payal
700 1 _aWaxman, Adam J
700 1 _aDomchek, Susan M
700 1 _aKy, Bonnie
773 0 _tJournal of the American College of Cardiology
_gvol. 73
_gno. 2
_gp. 248-249
856 4 0 _uhttps://doi.org/10.1016/j.jacc.2018.10.057
_zAvailable from publisher's website
999 _c29265706
_d29265706